This on-demand webinar will provide an overview of the regulatory framework in the US and Canada for developing drugs for rare diseases, outline available designations and regulatory pathways that can be used to expedite and accelerate treatments for rare diseases in each jurisdiction and the discuss the process and specific regulatory strategies for developing these drugs.

By completing this form, you submit your information to the webinar organizer, who will use it to communicate with you regarding this event and their other services.